Squarepoint
VAXX

Squarepoint’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Squarepoint’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-51,941
Closed -$118K – 4139
2023
Q1 		$118K Buy
+51,941
New +$132K ﹤0.01% 2939
2022
Q3 		– Sell
-15,417
Closed -$24K – 3574
2022
Q2 		$24K Buy
+15,417
New +$58.3K ﹤0.01% 2763

Other funds holding VAXX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
SM
Scoggin Management New York $1.04B AUM 232.32% 1-Year Est. Return

Squarepoint's VAXX Position: Q2 2023 in Review

Squarepoint sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2023, closing a stake of 51,941 shares — an estimated $118K sold.

Squarepoint first reported a position in VAXX in Q2 2022 and held it in 2 quarters. The position peaked at $118K in Q1 2023. 49 funds tracked by Wall St. Rank hold VAXX as of Q2 2023.

  • Squarepoint reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Squarepoint sold 51,941 Vaxxinity, Inc. Class A Common Stock shares in Q2 2023, an estimated $118K.
  • Squarepoint first reported a position in Vaxxinity, Inc. Class A Common Stock in Q2 2022 and held it in 2 quarters.
  • Squarepoint's Vaxxinity, Inc. Class A Common Stock position peaked at $118K in Q1 2023.
  • 49 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2023.

Based on Squarepoint's 13F filing for Q2 2023, filed 14 Aug 2023.